We came across a bullish thesis on Merck & Co., Inc. on R. Dennis’s Substack’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.'s share was trading at $106.90 as of January 28th. MRK’s trailing and forward P/E were 14.28 and 17.27 respectively according to Yahoo Finance.
[caption id="attachment_514321" align="aligncenter" width="750"]Merck & Co., Inc. operates as a healthcare company worldwide. MRK has emerged as the focus of a high-conviction bullish thesis following...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.